Home / Biotechnology / Global Bio

Global Biomarkers Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2030

The worldwide biomarkers market was valued at us$ 59.1 billion in 2022 and is projected to reach us$ 193.62 Bn by 2030, growing at a CAGR of 15.99%.

Growing expenditure on health care and research & development activities plus enhanced utility of biomarkers for diagnostics are predicted to stimulate the growth of the global biomarkers market. The growth and expansion of the industry will also be supported by the low prices of clinical trials in emerging nations and new initiatives taken by the firms in the biomarker research business.

On the other hand, factors like the requirement of heavy business investment, low cost-benefit ratio, poorly matched compensation methods and control systems, and the high price of tests and sample collection & storage are the key factors inhibiting the growth and expansion of the global biomarkers market. Further, the fast expansion of the I.T. sector, rapidly rising world population, and growing efforts by the scientific community to discover new medicines are few drivers stimulating the growth of the global biomarkers market.

Biomarkers are physically occurring genetic materials or molecules introduced to the target site or organ to monitor the physiological routes of the ailments. They are used as diagnostic means to evaluate the establishment as well the intensity of the ailment. These biomarkers also help doctors make accurate medical decisions and assist them in perfectly diagnosing the health of patients. Biomarkers' demand and their market growth are projected to enhance further owing to their medical applications in the field of cancer research and treatment. New market entrants in the global biomarkers market are predicted to generate new business growth avenues for the worldwide biomarkers market.

Biomarkers hold substantial significance in the area of drug discovery & development. It offers clarity on the ailment in terms of its ailment epidemiology. So the growing number of initiatives taken in the drug discovery & development field is the most substantial market growth driver. Further, the growing global occurrence of neurology, cardiology, and oncology-based ailments and stimulating initiatives taken by regulatory authorities like the U.S. food and drug administration will serve as the driver of the worldwide biomarker market.

The global biomarkers market is divided into products, types, applications, disease indications, and geographical regions.The worldwide biomarkers market by products includes Software, Consumables, and Services.

The global biomarkers market by types safety biomarkers, validation biomarkers, and efficacy biomarkers. Efficacy Biomarkers include Surrogate Biomarkers, Pharmacodynamic Biomarkers, Predictive Biomarkers, and Prognostic Biomarkers.

The worldwide biomarkers market by applications includes disease risk assessment, diagnostics development, personalized medicine, and drug discovery & development.

The drug discovery & development section leads the global biomarkers market in market share terms. This section is predicted to retain its leading position during the estimated period. Drug discovery & development carry high significance in the pharmaceuticals sector. The utilization of biomarkers in the procedure of drug discovery & development assists in increasing the procedure and judging failures of medicines or drugs. Such a capability of biomarkers to judge the failure of medicine and drugs saves the incurrence of high costs per the estimates of the U.S. food and drugs administration. Perfect drug/medicine failures predictions can save up to 100 million U.S. dollars for the drug producers.

The global biomarkers market by disease indications includes immunological disorders, cancer, neurological disorders, and heart or cardiovascular disorders.

The cancer section leads the worldwide biomarkers market. The high worldwide occurrence of cancer combined with a high level of patient consciousness contributes to the above-described fact. But, the heart disorder section is predicted to be the most profitable section in terms of business growth in the future. The rise in the occurrence of heart ailments and the presence of high unfulfilled medical requirements are few of the stimulators of the worldwide biomarkers market.

The worldwide biomarkers market by geographical regions includes the subcontinent of North America, the European continent, the Asia Pacific region, and the rest of the world.The sub-continent of North America contributes toward the biggest market share of the global biomarkers market. The presence of modern healthcare infrastructure facility, new product launches, availability of good research & development facility, high rate of adoption of modern techniques, entry of new industry players in the business/market sector, wide utilization of biomarkers, and incurrence of high per capita expenditure on healthcare activities are the factors expected to contribute towards the growth and development of the biomarkers market in North America. Further, strong development trends in contract research organizations and pharmaceutical firms in this sub-continent will add to the growth and expansion of the market in this North American sub-continent. This region is predicted to witness rapid market growth during the forecasted period.

The biomarkers market of the Asia Pacific region is predicted to expand at a rapid rate due to the growth of key biomarker firms, enhanced expenditure on research & development activities, increase in the amount of contract research organizations, and fast economic growth witnessed in countries like India and China of this region.

The key market players included in the market research report are as follows:

  • Bruker Corporation
  • Roche Diagnostics
  • Enzo Biochem Incorporation
  • Bio-Rad Laboratories
  • Epigenomics AG
  • PerkinElmer Incorporation
  • Meso Scale Diagnostics LLC
  • DiagnoCure Incorporation
  • Abbott Laboratories
  • Merck & Company Incorporation
  • EKF Diagnostics Holdings plc
  • BioSims Technologies
  • Johnson and Johnson
  • Diagnosis Incorporation
  • Singulex Incorporation
  • Cisbio Bioassays
  • Agilent Technologies Incorporation
  • Celera Corporation
  • G.E. Healthcare
  • Becton, Dickinson, and Company
  • Siemens Healthcare

The key industry participants in the worldwide biomarkers market are predicted to face tough competition from new market players. So it is necessary for the most prominent players in the industry to stay abreast with the new technological changes and adapt to fast-changing business and industry trends to gain a competitive advantage over their competitors in this business/market sector.


Frequently Asked Questions


The market for Biomarkers is expected to reach US$ 193.62 Bn By 2030.

The Biomarkers market is expected to see significant CAGR growth over the coming years, at 15.99%.

The report is forcasted to 2030.

The base year of this report is 2021.

QIAGEN N.V., Bruker Corporation, Roche Diagnostics, Enzo Biochem Incorporation, Bio-Rad Laboratories, Epigenomics AG, PerkinElmer Incorporation, Meso Scale Diagnostics LLC, DiagnoCure Incorporation, Abbott Laboratories, Merck & Company Incorporation,EKF Diagnostics Holdings plc are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Mar 2016
Category:  Biotechnology
Report ID:   57732
Report Format:   PDF
Pages:   120
Rating:    4.2 (65)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support